IDH1 and astrocytoma (excluding glioblastoma): Brendle et al. demonstrated that CBF by ASL perfusion enabled discrimination of astrocytomas with and without IDH mutation (p = 0.014, sensitivity = 0.75, specificity = 0.88), however, grade II, III and IV tumors were included for this analysis [58].